Leukotrienes in renal transplant rejection in rats: Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury

Robert F. Spurney, Sherif Ibrahim, David Butterly, Paul E. Klotman, Fred Sanfilippo, Thomas M. Coffman

Research output: Contribution to journalArticle

Abstract

To investigate the role of leukotrienes in renal allograft rejection, we studied the effects of specific leukotriene inhibitors in a rat kidney transplant model. The enhanced renal production of leukotrienes observed in allograft recipients was reduced in a dose-dependent manner by the specific 5-lipoxygenase inhibitor MK886. This suppression of leukotriene production caused a substantial improvement in renal function. Inhibition of 5- lipoxygenase also reduced the severity of vascular inflammation and endothelial injury in allografts, and profoundly inhibited expression of donor MHC class II Ag on kidney cells. Survival of renal allograft recipients was prolonged from 10 ± 1 days in controls to 16 ± 1 days in animals that received a 6-day course of MK886 (p <0.05). To investigate the relative roles of LTB4 compared to peptidoleukotrienes in these processes, we treated a separate group of animals with the specific peptidoleukotriene receptor antagonist SKF106203. This agent inhibits the interaction of peptidoleukotrienes with their receptor(s) but does not affect the biologic actions of LTB4. In these studies, SKF106203 caused a modest improvement in renal allograft function that was of lesser magnitude than that seen with the 5-lipoxygenase inhibitor. SKF106203 also reduced vascular inflammation in allografts, but had no effect on expression of MHC class II Ag. We conclude that leukotrienes play a key role in the pathogenesis of renal allograft rejection. Furthermore, the detrimental effects of leukotrienes in rejection are mediated by distinct actions of LTB4 and peptidoleukotrienes.

Original languageEnglish (US)
Pages (from-to)867-876
Number of pages10
JournalJournal of Immunology
Volume152
Issue number2
StatePublished - Jan 15 1994
Externally publishedYes

Fingerprint

Leukotriene B4
Leukotrienes
Graft Rejection
Allografts
Kidney
Wounds and Injuries
Lipoxygenase Inhibitors
Blood Vessels
Inflammation
Arachidonate 5-Lipoxygenase
Transplants

ASJC Scopus subject areas

  • Immunology

Cite this

Spurney, R. F., Ibrahim, S., Butterly, D., Klotman, P. E., Sanfilippo, F., & Coffman, T. M. (1994). Leukotrienes in renal transplant rejection in rats: Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury. Journal of Immunology, 152(2), 867-876.

Leukotrienes in renal transplant rejection in rats : Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury. / Spurney, Robert F.; Ibrahim, Sherif; Butterly, David; Klotman, Paul E.; Sanfilippo, Fred; Coffman, Thomas M.

In: Journal of Immunology, Vol. 152, No. 2, 15.01.1994, p. 867-876.

Research output: Contribution to journalArticle

Spurney, RF, Ibrahim, S, Butterly, D, Klotman, PE, Sanfilippo, F & Coffman, TM 1994, 'Leukotrienes in renal transplant rejection in rats: Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury', Journal of Immunology, vol. 152, no. 2, pp. 867-876.
Spurney, Robert F. ; Ibrahim, Sherif ; Butterly, David ; Klotman, Paul E. ; Sanfilippo, Fred ; Coffman, Thomas M. / Leukotrienes in renal transplant rejection in rats : Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury. In: Journal of Immunology. 1994 ; Vol. 152, No. 2. pp. 867-876.
@article{5efd6b8833044215a097ab9714b6a28e,
title = "Leukotrienes in renal transplant rejection in rats: Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury",
abstract = "To investigate the role of leukotrienes in renal allograft rejection, we studied the effects of specific leukotriene inhibitors in a rat kidney transplant model. The enhanced renal production of leukotrienes observed in allograft recipients was reduced in a dose-dependent manner by the specific 5-lipoxygenase inhibitor MK886. This suppression of leukotriene production caused a substantial improvement in renal function. Inhibition of 5- lipoxygenase also reduced the severity of vascular inflammation and endothelial injury in allografts, and profoundly inhibited expression of donor MHC class II Ag on kidney cells. Survival of renal allograft recipients was prolonged from 10 ± 1 days in controls to 16 ± 1 days in animals that received a 6-day course of MK886 (p <0.05). To investigate the relative roles of LTB4 compared to peptidoleukotrienes in these processes, we treated a separate group of animals with the specific peptidoleukotriene receptor antagonist SKF106203. This agent inhibits the interaction of peptidoleukotrienes with their receptor(s) but does not affect the biologic actions of LTB4. In these studies, SKF106203 caused a modest improvement in renal allograft function that was of lesser magnitude than that seen with the 5-lipoxygenase inhibitor. SKF106203 also reduced vascular inflammation in allografts, but had no effect on expression of MHC class II Ag. We conclude that leukotrienes play a key role in the pathogenesis of renal allograft rejection. Furthermore, the detrimental effects of leukotrienes in rejection are mediated by distinct actions of LTB4 and peptidoleukotrienes.",
author = "Spurney, {Robert F.} and Sherif Ibrahim and David Butterly and Klotman, {Paul E.} and Fred Sanfilippo and Coffman, {Thomas M.}",
year = "1994",
month = "1",
day = "15",
language = "English (US)",
volume = "152",
pages = "867--876",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "2",

}

TY - JOUR

T1 - Leukotrienes in renal transplant rejection in rats

T2 - Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury

AU - Spurney, Robert F.

AU - Ibrahim, Sherif

AU - Butterly, David

AU - Klotman, Paul E.

AU - Sanfilippo, Fred

AU - Coffman, Thomas M.

PY - 1994/1/15

Y1 - 1994/1/15

N2 - To investigate the role of leukotrienes in renal allograft rejection, we studied the effects of specific leukotriene inhibitors in a rat kidney transplant model. The enhanced renal production of leukotrienes observed in allograft recipients was reduced in a dose-dependent manner by the specific 5-lipoxygenase inhibitor MK886. This suppression of leukotriene production caused a substantial improvement in renal function. Inhibition of 5- lipoxygenase also reduced the severity of vascular inflammation and endothelial injury in allografts, and profoundly inhibited expression of donor MHC class II Ag on kidney cells. Survival of renal allograft recipients was prolonged from 10 ± 1 days in controls to 16 ± 1 days in animals that received a 6-day course of MK886 (p <0.05). To investigate the relative roles of LTB4 compared to peptidoleukotrienes in these processes, we treated a separate group of animals with the specific peptidoleukotriene receptor antagonist SKF106203. This agent inhibits the interaction of peptidoleukotrienes with their receptor(s) but does not affect the biologic actions of LTB4. In these studies, SKF106203 caused a modest improvement in renal allograft function that was of lesser magnitude than that seen with the 5-lipoxygenase inhibitor. SKF106203 also reduced vascular inflammation in allografts, but had no effect on expression of MHC class II Ag. We conclude that leukotrienes play a key role in the pathogenesis of renal allograft rejection. Furthermore, the detrimental effects of leukotrienes in rejection are mediated by distinct actions of LTB4 and peptidoleukotrienes.

AB - To investigate the role of leukotrienes in renal allograft rejection, we studied the effects of specific leukotriene inhibitors in a rat kidney transplant model. The enhanced renal production of leukotrienes observed in allograft recipients was reduced in a dose-dependent manner by the specific 5-lipoxygenase inhibitor MK886. This suppression of leukotriene production caused a substantial improvement in renal function. Inhibition of 5- lipoxygenase also reduced the severity of vascular inflammation and endothelial injury in allografts, and profoundly inhibited expression of donor MHC class II Ag on kidney cells. Survival of renal allograft recipients was prolonged from 10 ± 1 days in controls to 16 ± 1 days in animals that received a 6-day course of MK886 (p <0.05). To investigate the relative roles of LTB4 compared to peptidoleukotrienes in these processes, we treated a separate group of animals with the specific peptidoleukotriene receptor antagonist SKF106203. This agent inhibits the interaction of peptidoleukotrienes with their receptor(s) but does not affect the biologic actions of LTB4. In these studies, SKF106203 caused a modest improvement in renal allograft function that was of lesser magnitude than that seen with the 5-lipoxygenase inhibitor. SKF106203 also reduced vascular inflammation in allografts, but had no effect on expression of MHC class II Ag. We conclude that leukotrienes play a key role in the pathogenesis of renal allograft rejection. Furthermore, the detrimental effects of leukotrienes in rejection are mediated by distinct actions of LTB4 and peptidoleukotrienes.

UR - http://www.scopus.com/inward/record.url?scp=0028265538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028265538&partnerID=8YFLogxK

M3 - Article

C2 - 8283057

AN - SCOPUS:0028265538

VL - 152

SP - 867

EP - 876

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 2

ER -